Results 211 to 220 of about 89,290 (238)

Clinical Outcomes and Safety of Meropenem–Colistin versus Meropenem–Tigecycline in Patients with Carbapenem-Resistant Acinetobacter baumannii Pneumonia

Antibiotics, 2021
Jaemin Park, Kyung-Sook Yang, Jeong Yeon Kim   +2 more
exaly  

In vitro activity of carvacrol in combination with meropenem against carbapenem-resistant Klebsiella pneumoniae

Folia Microbiologica (Prague), 2021
E. Köse
semanticscholar   +1 more source

Meropenem

Reactions Weekly, 2014
openaire   +2 more sources

Meropenem

Reactions Weekly, 2019
openaire   +2 more sources

Early Experience With Meropenem-Vaborbactam for Treatment of Carbapenem-resistant Enterobacteriaceae Infections

Clinical Infectious Diseases, 2020
Liang Chen, Erin Mccreary, Hung T Nguyen   +2 more
exaly  

Meropenem

Reactions Weekly, 2013
openaire   +1 more source

Effect of Empirical Treatment With Moxifloxacin and Meropenem vs Meropenem on Sepsis-Related Organ Dysfunction in Patients With Severe Sepsis

JAMA - Journal of the American Medical Association, 2012
Axel Nierhaus, Frank Bloos, Claudia Spies   +2 more
exaly  

Meropenem

Drugs, 2012
Harriet M Lamb, Lamb Harriet M
exaly  

Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae

Antimicrobial Agents and Chemotherapy, 2017
Rodrigo Mendes, Michael Huband, Mariana Castanheira   +2 more
exaly  

Imipenem–Relebactam and Meropenem–Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations

Drugs, 2017
G. Zhanel, Courtney K. Lawrence, H. Adam, F. Schweizer, S. Zelenitsky, Michael A. Zhanel, P. Lagacé-Wiens, A. Walkty, A. Denisuik, A. Golden, A. Gin, D. Hoban, J. Lynch, J. Karlowsky   +13 more
semanticscholar   +1 more source